What’s Happening With Alnylam Stock?
- Monday, November 1, 2021, 7:10
- Market
- Add a comment
The stock price of Alnylam Pharmaceuticals, a pharmaceutical company focused on RNA interference therapeutics for genetically defined diseases, plunged over 15% in yesterday’s trading session, following its Q3 results, which were much lower than the Wall Street estimates. The company reported…
About the Author
admin123 has written 23412 stories on this site.
